SAVAL Pharmaceuticals continues to grow in Latin America

SAVAL Pharmaceuticals announced its entry into the pharmaceutical market in Costa Rica through the acquisition of the Stein production plant in Cartago.

The facilities cover ~9,000 m2 approximately, with the capacity to manufacture solid products (tablets, capsules, among others) and liquids (syrups).

This new operation responds to the company's 2030 Strategic Plan to strengthen its international positioning.

This operation will allow more than 20 SAVAL products in the neuroscience, cardiology and ophthalmology lines to be available to the population of Costa Rica and other countries in the region in the short term. Thus, seeking to contribute to the health care of people also in Central America and the Caribbean.